USEUROPEAFRICAASIA 中文双语Français
Home / World

$260m deal reached to avert federal trial on opioid crisis

By Scott Reeves in New York | China Daily | Updated: 2019-10-23 08:05

Three major US drug distributors and a drug manufacturer reached a $260 million settlement on Monday to avoid a trial in federal court seeking to affix blame for stoking the opioid crisis in two Ohio counties.

Drug distributors McKesson, Cardinal Health and Amerisource-Bergen agreed to pay the counties a total of $215 million. Teva Pharmaceutical Industries, an Israel-based drugmaker, agreed to pay $20 million over the next two years and donate addiction-treatment drugs valued at $25 million.

Cuyahoga and Summit counties, which include the cities of Cleveland and Akron, sought to recover costs incurred during the opioid epidemic, including medical care, emergency services and foster care for children born to addicted parents.

$260m deal reached to avert federal trial on opioid crisis

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US